SAN DIEGO, July 13, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Imprivata, Inc. (NYSE: IMPR) breached their fiduciary duties in connection with the proposed sale of the Company to an affiliate of Thoma Bravo, LLC.
Additional Information: Imprivata is an IT security company that provides authentication and access management technology solutions for the healthcare industry in the United States, the United Kingdom, and internationally.
On July 13, 2016, Imprivata announced it had signed a definitive merger agreement with Thoma Bravo. Under the terms of the agreement, Imprivata stockholders will receive $19.25 per share in cash.
The investigation concerns whether the Imprivata board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Imprivata shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration; especially given that the price target for one Wall Street analyst is $20.00. The 52-week high for Imprivata stock is $21.63.
If you are a shareholder of Imprivata and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number where you can be reached.
About Johnson & Weaver, LLP: Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.